Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2023 ∙ Wang, X. Haeussler, K. Spellman, A. Phillips, L. E. Ramiller, A. Bausch-Jurken, M. T. Sharma, P. Krivelyova, A. Vats, S. Van de Velde, N.

Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Lin, R. Jin, H. Fu, X.

Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Hossaini, S. Keramat, F. Cheraghi, Z. Zareie, B. Doosti-Irani, A.

Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Barbateskovic, M. Klingenberg, S. L. Krauss, S. R. Kong, D. Wu, Z. Petersen, S. B. Kenfelt, M. Gluud, C.

Concentrations, Number of Doses, and Formulations of Aluminium Adjuvants in Vaccines: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Passanante, A. Pertwee, E. Lin, L. Lee, K. Y. Wu, J. T. Larson, H. J.

Conversational AI and Vaccine Communication: Systematic Review of the Evidence

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Kuziez, L. Eleiwa, T. K. Chauhan, M. Z. Sallam, A. B. Elhusseiny, A. M. Saeed, H. N.

Corneal Adverse Events Associated with SARS-CoV-2/COVID-19 Vaccination: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Teferi, G. Kefale, B.

Coronavirus vaccine acceptance in Ethiopia: Systematic review and meta-analysis

  • Africa
  • Ethiopia
  • All age groups
  • Healthcare workers
  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Zhou, Q. Liu, Y. Zeng, F. Meng, Y. Liu, H. Deng, G.

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Moderate
2023 ∙ He, Y. F. Ouyang, J. Hu, X. D. Wu, N. Jiang, Z. G. Bian, N. Wang, J.

Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wittenauer, Rachel Pecenka, Clint Baral, Ranju

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective

  • Newborn
  • Children
  • Pregnant women
  • Low and Middle Income Countries
  • RSV (Respiratory syncytial virus)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...